B. Braun Settles Patent Case, Signs Non-exclusive License with Mallinckrodt
shot by IP News Shots / 1:15 pm on 05 October, 2020
The settlement of a patent infringement suit has been confirmed by B. Braun Medical Inc. which will now result in the signing of a non-exclusive deal. The plaintiffs Mallinckrodt Hospital Products Inc., its affiliates and New Pharmatop L.P. have granted non-exclusive license to B. Braun for the launch of a competing intravenous acetaminophen product in the US. The patent infringement lawsuit had been filed by the plaintiffs in response to B. Braun’s New Drug Application (NDA) for the same product.
Industry: Pharmaceuticals | Type of IP: Deals - Licensing, Litigations